AUTHOR=Zhang Lei , Wang Yanan , Li Yi , Li Lingli , Xu Suowen , Feng Xiaojun , Liu Sheng 

TITLE=Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases

JOURNAL=Frontiers in Pharmacology

VOLUME=9

YEAR=2018

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01066

DOI=10.3389/fphar.2018.01066

ISSN=1663-9812

ABSTRACT=<p>Cardiovascular disease is the main cause of death worldwide, but its pathogenesis is not yet clear. Hydrogen sulfide (H<sub>2</sub>S) is considered to be the third most important endogenous gasotransmitter in the organism after carbon monoxide and nitric oxide. It can be synthesized in mammalian tissues and can freely cross the cell membrane and exert many biological effects in various systems including cardiovascular system. More and more recent studies have supported the protective effects of endogenous H<sub>2</sub>S and exogenous H<sub>2</sub>S-releasing compounds (such as NaHS, Na<sub>2</sub>S, and GYY4137) in cardiovascular diseases, such as cardiac hypertrophy, heart failure, ischemia/reperfusion injury, and atherosclerosis. Here, we provided an up-to-date overview of the mechanistic actions of H<sub>2</sub>S as well as the therapeutic potential of various classes of H<sub>2</sub>S donors in treating cardiovascular diseases.</p>